Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Lee, Kang Woo ^a   Jung, So Y ^a   Choi, Sun Mi ^a   Yang, Eun J ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

BV2 microglial cell; Ginsenoside Re (G Re); Neuroinflammation; Phospho p38MAPK

Indexed keywords

CYCLOOXYGENASE 2; GINSENOSIDE RE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; SYNAPTOPHYSIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84867826588     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-196     Document Type: Article

References (35)

1. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173:3916-3924.
2. Block ML, Hong JS. Microglia and inflammationmediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
3. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291. 10.1212/WNL.38.8.1285, 3399080.
4. Choi Y, Lee MK, Lim SY, Sung SH, Kim YC. Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells. Br J Phamrmacol 2009, 156:933-940.
5. Brown GC, Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010, 41:242-247. 10.1007/s12035-010-8105-9, 20195798.
6. Paolo M, Massimiliano R, Elena D, Eleonora R, Giangiacomo B, Roberto MF. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-a and NF-kB nuclear translocation in BV-2 microglia. Phytother Res 2012, 26:1405-1409. 10.1002/ptr.3732, 22359368.
7. Christina S, Sandra ZF, Kristin P, Katarina R, Tiit L. LPS-induced iNOS expression in Bv-2 cells is suppressed by an oxidative mechanism acting on the JNK pathway-a potential role for neuroprotection. Brain Res 2010, 1322:1-7.
8. Godbout JP, Berg BM, Kelley KW, Johnson RW. Alpha- Tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J Neuroimmunol 2004, 149:101-109. 10.1016/j.jneuroim.2003.12.017, 15020070.
9. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192:1-15. 10.1002/jcp.10119, 12115731.
10. Ajmone-Cat MA, De Simone R, Nicolini A, Minghetti L. Effects of phosphatidylserine on p38 mitogen activated protein kinase, cyclic AMP responding element binding protein and nuclear factor-kappaB activation in resting and activated microglial cells. J Neurochem 2003, 84:413-416. 10.1046/j.1471-4159.2003.01562.x, 12559004.
11. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51:1851-1858. 10.2337/diabetes.51.6.1851, 12031973.
12. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ, Yuan CS. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006, 532:201-207. 10.1016/j.ejphar.2006.01.001, 16497296.
13. Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang R, Li X. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int Immunophamacol 2007, 7:313-320.
14. Bae EA, Trinh HT, Yoon HK, Kim DH. Compound K, a metabolite of ginsenoside Rb1, inhibits passive cutaneous anaphylaxis reaction in mice. J Ginseng Res 2009, 33:93-98.
15. Ro JY, Ahn YS, Kim KH. Inhibitory effect of ginsenoside on the mediator release in the guinea pig lung mast cells activated by specific antigen-antibody reactions. Int J Immunopharmacol 1998, 20:625-641. 10.1016/S0192-0561(98)00062-9, 9848395.
16. Lee SM, Yang EJ, Choi SM, Kim SH, Baek MG, Jiang JH. Effects of bee venom on glutamate-induced toxicity in neuronal and glial cells. Evid Based Complement Alternat Med 2012, 2012:368196-368205. 3166716, 21904562.
17. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999, 55:567-575. 10.1007/s002280050674, 10541774.
18. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003, 75:687-700. 10.1016/S0091-3057(03)00126-6, 12895687.
19. Zhang Z, Li X, Lv W, Yang Y, Gao H, Yang J, Shen Y, Ning G. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. Mol Endocrinol 2008, 22:186-195.
20. Lee B, Shim I, Lee H, Hahm DH. Effect of ginsenoside re on depression- and anxiety-like behaviors and cognition memory deficit induced by repeated immobilization in rats. J Microbiol Biotechnol 2012, 22:708-720. 10.4014/jmb.1112.12046, 22561867.
21. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007, 8:766-775. 10.1038/nrn2214, 17882254.
22. Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, Bian LG, Ai QL, Liu YD, Sun J, Lu D. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One 2011, 6:e21891. 10.1371/journal.pone.0021891, 3134470, 21765922.
23. Bachstetter AD, Xing B, de Almeida L, Dimayuga ER, Watterson DM, Van Eldik LJ. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ). J Neuroinflammation 2011, 8:79. 10.1186/1742-2094-8-79, 3142505, 21733175.
24. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol 2011, 82:278-286. 10.1016/j.bcp.2011.05.003, 21600888.
25. Hu JF, Song XY, Chu SF, Chen J, Ji HJ, Chen XY, Yuan YH, Han N, Zhang JT, Chen NH. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res 2011, 1374:8-14.
26. Kwok HH, Ng WY, Yang MS, Mak NK, Wong RN, Yue PY. The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med 2010, 48:437-445. 10.1016/j.freeradbiomed.2009.11.013, 19932166.
27. Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int 2011, 58:119-125. 10.1016/j.neuint.2010.11.004, 21078355.
28. Li N, Liu B, Dluzen DE, Jin Y. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol 2007, 111:458-463. 10.1016/j.jep.2006.12.015, 17257792.
29. Chen XC, Fang F, Zhu YG, Chen LM, Zhou YC, Chen Y. Protective effect of ginsenoside Rg1 on MPP+-induced apoptosis in SHSY5Y cells. J Neural Transm 2003, 110:835-845. 10.1007/s00702-003-0005-y, 12898340.
30. Xie X, Wang HT, Li CL, Gao XH, Ding JL, Zhao HH, Lu YL. Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury. Mol Med Report 2010, 3:635-639.
31. Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A. Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord Drug Targets 2011, 10:621-634.
32. Spitzbarth I, Baumgärtner W, Beineke A. The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases. Vet Immunol Immunopathol 2012, 147:6-24. 10.1016/j.vetimm.2012.04.005, 22542984.
33. Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999, 72:2415-2425.
34. Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience 2009, 162:1220-1231. 10.1016/j.neuroscience.2009.05.019, 19447162.
35. Hoang T, Choi DK, Nagai M, Wu DC, Nagata T, Prou D, Wilson GL, Vila M, Jackson-Lewis V, Dawson VL, Dawson TM, Chesselet MF, Przedborski S. Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radic Biol Med 2009, 47:1049-1056. 10.1016/j.freeradbiomed.2009.07.013, 19616617.